Squarepoint Ops LLC - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 86 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$529,110
+30.7%
222,315
-3.3%
0.00%0.0%
Q2 2023$404,800
-23.5%
230,000
+33.8%
0.00%
-50.0%
Q1 2023$529,283
+295.0%
171,845
+1304.7%
0.00%
+100.0%
Q4 2020$134,000
+34.0%
12,234
+8.6%
0.00%0.0%
Q3 2020$100,00011,2650.00%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$2,692,0001.92%
SILVERARC CAPITAL MANAGEMENT, LLC 380,606$982,0000.30%
Pentwater Capital Management LP 4,967,227$12,815,0000.15%
Atom Investors LP 55,827$144,0000.06%
Corton Capital Inc. 14,978$39,0000.04%
Forefront Analytics, LLC 23,370$61,0000.03%
Delphia (USA) Inc. 15,799$41,0000.03%
Advisory Services Network, LLC 259,571$670,0000.02%
Laurion Capital Management LP 545,700$1,408,0000.02%
MCF Advisors LLC 59,659$154,0000.02%
View complete list of POSEIDA THERAPEUTICS INC shareholders